Skip to content
Menu

ONE Bio Corp. ONBI

Full chart Compare
Set alert

Price alert · ONBI

All alert types
0.00 USD 0.00 (+0.00%)

Regular-session close

0.003 Day range 0.003
0.0002 52-week range 0.003
YTD
0.00%
1 year
+150.00%

Fundamental scorecard

10 of 25 checks passed on ONBI’s reported financials

ValueGrowthProfitabilityHealthDividend

10of 25 checks passed

  • Value 2 of 5
  • Growth 1 of 5
  • Profitability 2 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2011.

Value 2 of 5

  • No data:P/E below its own 5-year median P/E 0.0. Not enough data to decide.
  • Passed:P/E under 20 P/E 0.0: an earnings yield of 221025.1%.
  • No data:Price to sales below its own 5-year median Price to sales 0.0. Not enough data to decide.
  • No data:Price to book below its own 5-year median Price to book 0.0. Not enough data to decide.
  • Passed:Free cash flow yield above 4% Free cash flow of 5.71M is 134886.3% of the market value.

Growth 1 of 5

  • Passed:Revenue grew over the last year Revenue of 53.9M is +6.1% on the 12 months before.
  • No data:Revenue grew more than 5% a year over five years Not enough data to decide.
  • Failed:Earnings per share grew over the last year EPS 1.31 against 1.37 in the 12 months before.
  • No data:Earnings per share grew more than 5% a year over five years Not enough data to decide.
  • No data:Analysts expect higher earnings per share over the next year No analyst estimate.

Profitability 2 of 5

  • Passed:Profitable over the last year Net income of 9.36M over the last 12 months.
  • No data:Profitable in each of the last five fiscal years Not enough data to decide.
  • Passed:Return on equity above 15% Return on equity of 21.8%.
  • Failed:Net margin above its 5-year average Net margin of 17.4% against a 5-year average of 23.5%.
  • Failed:Free cash flow is at least 80% of net income Free cash flow of 5.71M is 61.0% of net income.

Financial health 5 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 49.8M against short-term liabilities of 31.6M.
  • Passed:Short-term assets cover long-term liabilities Short-term assets of 49.8M against long-term liabilities of 1.49M.
  • Passed:Net debt under 40% of equity Net debt of 3.90M is 8.0% of equity.
  • Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 14.5M is 55.6% of debt.
  • Passed:Operating profit covers interest at least 3 times Operating profit is 11.0 times the interest expense.

Dividend 0 of 5

  • Failed:Pays a dividend No dividend paid.
  • Failed:Yield above 1.5% No dividend paid.
  • Failed:Pays out under 75% of profit No dividend paid.
  • Failed:Covered by free cash flow No dividend paid.
  • Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What ONBI owns and owes, as of Sep 30, 2011

Short term and long term

Balance sheet · 82.9M of assets

Debt, equity and cash by year

Now: 3.90M of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

1.95 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 4.5×
P/S 0.8×
P/B 0.9×
P/FCF 8.5×
EV/EBITDA 3.6×
EV/Sales 0.9×
FCF Yield 11.7%

Profitability

Gross Margin 38.5%
Operating Margin 26.2%
Net Margin 16.6%
ROE 20.6%
ROIC 16.1%
ROA 12.4%

Growth (YoY)

Revenue 136.9%
Operating Income 83.4%
EPS (diluted) 45.2%
Free Cash Flow 313.8%

Financial Health

Current Ratio 1.5×
Quick Ratio 1.3×
Debt / Equity 0.5×
Net Debt / EBITDA 0.7×
Interest Coverage 18.6×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2010-12-31